Work Placement and Job Satisfaction in Long-Term Childhood Cancer Survivors: The Impact of Late Effects.
childhood cancer survivors
job satisfaction
late effects
occupation
satisfaction profile
work placement
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
18 Aug 2022
18 Aug 2022
Historique:
received:
20
07
2022
revised:
11
08
2022
accepted:
16
08
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
Late effects of cancer and its treatments during childhood or adolescence can impact work placement and increase the risk of unemployment. The aim of this study is to describe the work placement and the perceived job and economic satisfaction of long-term childhood cancer survivors (CCS). Jobs have been categorized according to the International Standard Classification of Occupations version 08 (ISCO-08), and satisfaction has been evaluated through the Satisfaction Profile (SAT-P). Out of 240 CCS (female = 98) included: 53 were students, 46 were unemployed and 141 were employed. Within unemployed survivors, 89.13% were affected by late effects (n = 41). The presence of at least one severe late effect was significantly associated with the probability of unemployment (OR 3.21; 95% CI 1.13−9.12, p < 0.050), and having any late effect was inversely related to the level of satisfaction of the financial situation of unemployed CCS (b −35.47; 95% CI −59.19, −11.74, p = 0.004). Our results showed that being a survivor with severe comorbidities has a significantly negative impact on occupation and worsens the perception of satisfaction of economic situations. Routinary follow-up care of CCS should include the surveillance of socioeconomic development and provide interventions, helping them to reach jobs suitable for their health.
Identifiants
pubmed: 36010976
pii: cancers14163984
doi: 10.3390/cancers14163984
pmc: PMC9406576
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Lancet Reg Health Eur. 2021 Nov 30;12:100258
pubmed: 34901911
Qual Life Res. 2014 Oct;23(8):2213-24
pubmed: 24729054
Int J Cancer. 2017 Jun 15;140(12):2678-2692
pubmed: 28316069
J Clin Oncol. 2018 Jul 20;36(21):2190-2197
pubmed: 29874134
Br J Cancer. 2016 Apr 26;114(9):1060-8
pubmed: 27115571
Front Psychol. 2019 Oct 23;10:2371
pubmed: 31708832
Support Care Cancer. 2021 Nov;29(11):6661-6668
pubmed: 33961121
Med Care. 2010 Nov;48(11):1015-25
pubmed: 20940653
Workplace Health Saf. 2021 Nov;69(11):506-516
pubmed: 34039084
Eur J Endocrinol. 2013 Feb 20;168(3):465-72
pubmed: 23258270
Pediatr Blood Cancer. 2011 Mar;56(3):432-8
pubmed: 21072822
Pediatr Int. 2020 Nov;62(11):1241-1249
pubmed: 32402092
Health Qual Life Outcomes. 2018 Jan 30;16(1):26
pubmed: 29382346
Cancer Epidemiol Biomarkers Prev. 2017 May;26(5):666-674
pubmed: 28035022
BMC Surg. 2012;12 Suppl 1:S10
pubmed: 23173648
Children (Basel). 2022 Mar 14;9(3):
pubmed: 35327783
Cancer. 2022 Jul 1;128(13):2405-2419
pubmed: 35435238